Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pivotal Life Sciences is a global healthcare investment firm established in 2017 that supports and manages investments in life sciences companies developing high-impact therapeutics for significant unmet medical needs. It operates as the asset management platform of Nan Fung Life Sciences and has invested across North America and Europe through its venture arms such as Pivotal bioVenture Partners. The firm participates actively from early-stage company building to late-stage private rounds and public markets. Its latest fund closed with $389 million in capital commitments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pivot Life Sciences.